- Filed
- Mar 5, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 3, 2025 | 192.7M sh |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $117.31M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $167.31M |
| Current Assets | FY 2024 · Dec 31, 2023 | $340.34M |
| Total Assets | FY 2024 · Dec 31, 2023 | $509.76M |
| Shares Diluted restated | FY 2024 · Dec 31, 2022 | 195.58M sh |
| Capex | FY 2024 · Dec 31, 2022 | $1.11M |
| Operating Cash Flow restated | FY 2024 · Dec 31, 2022 | −$77.83M |
| Cash And Equivalents | FY 2024 · Dec 31, 2022 | $210.41M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | −$0.49 |
| Eps Basic | FY 2024 · Dec 31, 2022 | −$0.49 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $55.31M |
| Rd Expense | FY 2024 · Dec 31, 2022 | $29.42M |
| Net Income | FY 2024 · Dec 31, 2022 | −$96.32M |
| Operating Income | FY 2024 · Dec 31, 2022 | −$104.25M |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $166.47M |
| Revenue | FY 2024 · Dec 31, 2022 | $167.82M |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $449.5M |